Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
- Oktober -
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
- 2012 -
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
Oktober 2012 - 49 products
L
IP
PP
Eylea 8 mg/0.07 ml
845.90
936.40
10 %
Injection solution: Afliberceptum 8mg / 0.07ml
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
Sildenafil axapharm 50 mg
24
PR
PR
k.A.
Coated tablets: Sildenafilum 50 mg
axapharm ag
B
FB
G
L
IP
Dacogen
Durchstechflasche(n)
890.92
979.75
10 %
Lyophilisat zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung: Decitabinum 50 mg
Janssen-Cilag AG
A / SL / SO
FB
G
IP
CI
Dorzo-Vision 2 %
5 ml
9.85
27.15
10 %
Eye drops: Dorzolamidum 20 mg/ml
OmniVision AG
B / SL / SG
FB
G
IP
CI
Dorzo-Vision 2 %
3 x 5 ml
21.50
39.80
10 %
Eye drops: Dorzolamidum 20 mg/ml
OmniVision AG
B / SL / SG
FB
G
IP
CI
Levocetirizin-Mepha
10 Tablet(s)
2.59
4.75
10 %
Coated tablets: Levocetirizini Dihydrochloridum 5 mg
Mepha Pharma AG
D / SL / SG
FB
G
IP
CI
Levocetirizin-Mepha
30 Tablet(s)
7.02
12.95
10 %
Coated tablets: Levocetirizini Dihydrochloridum 5 mg
Mepha Pharma AG
D / SL / SG
FB
G
IP
CI
Levocetirizin-Mepha
50 Tablet(s)
11.48
21.20
10 %
Coated tablets: Levocetirizini Dihydrochloridum 5 mg
Mepha Pharma AG
D / SL / SG
FB
G
IP
CI
Telmisartan Sandoz 40 mg
28 Tablet(s)
13.28
30.90
10 %
Tablets: Telmisartanum 40 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Telmisartan Sandoz 40 mg
98 Tablet(s)
42.80
63.05
10 %
Tablets: Telmisartanum 40 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Telmisartan Sandoz 80 mg
28 Tablet(s)
15.97
33.85
10 %
Tablets: Telmisartanum 80 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Telmisartan Sandoz 80 mg
98 Tablet(s)
55.43
76.80
10 %
Tablets: Telmisartanum 80 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
PP
Eylea, 2 mg/0,05 ml
Durchstechflasche(n)
845.90
936.40
10 %
Injection solution: Afliberceptum 2mg / 0.05ml
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
Jentadueto 2.5 mg/500 mg
60 Tablet(s)
37.85
57.60
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
Jentadueto 2.5 mg/500 mg
180
113.55
139.90
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
Jentadueto 2.5 mg/850 mg
60 Tablet(s)
37.85
57.60
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
Jentadueto 2.5 mg/850 mg
180
113.55
139.90
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
Jentadueto 2.5 mg/1000 mg
60 Tablet(s)
37.85
57.60
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
Jentadueto 2.5 mg/1000 mg
180
113.55
139.90
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
PP
Eylea
845.90
936.40
10 %
Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl
Bayer (Schweiz) AG
B / SL
FB
G
IP
Dexdor 400ug/4ml
4 Durchstechflasche(n)
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 400µg / 4ml
Orion Pharma AG
A
FB
G
IP
Dexdor 1000ug/10ml
4 Durchstechflasche(n)
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 1000µg / 10ml
Orion Pharma AG
A
FB
G
IP
Dexdor 200ug/2ml
5 ampoule(s)
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 200µg / 2ml
Orion Pharma AG
A
FB
G
IP
Dexdor 200ug/2ml
25 ampoule(s)
PR
PR
k.A.
Concentrate for infusion: Dexmedetomidinum 200µg / 2ml
Orion Pharma AG
A
FB
G
IP
CI
Diclo-Acino 100 retard
10 Capsule(s)
PR
PR
k.A.
Delayed release capsules: Diclofenacum Natricum 100 mg
Acino Pharma AG
B
FB
G
IP
CI
Diclo-Acino 100 retard
30 Capsule(s)
PR
PR
k.A.
Delayed release capsules: Diclofenacum Natricum 100 mg
Acino Pharma AG
B
FB
G
IP
CI
Diclo-Acino 100 retard
100 Capsule(s)
PR
PR
k.A.
Delayed release capsules: Diclofenacum Natricum 100 mg
Acino Pharma AG
B
FB
G
IP
CI
Diclo-Acino 75 retard
20 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Diclofenacum Natricum 75 mg
Acino Pharma AG
B
FB
G
IP
CI
Diclo-Acino 75 retard
100 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Diclofenacum Natricum 75 mg
Acino Pharma AG
B
FB
G
IP
CI
Levocetirizin-Mepha
100 Tablet(s)
PR
PR
k.A.
Coated tablets: Levocetirizini Dihydrochloridum 5 mg
Mepha Pharma AG
D
FB
G
IP
CI
PP
PRILIGY
3 Tablet(s)
PR
PR
k.A.
Coated tablets: Dapoxetinum 30 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
PRILIGY
6 Tablet(s)
PR
PR
k.A.
Coated tablets: Dapoxetinum 30 mg
A. Menarini GmbH
B
FB
G
IP
CI
Sildenafil axapharm 25 mg
4 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 25 mg
axapharm ag
B
FB
G
IP
CI
Sildenafil axapharm 25 mg
12 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 25 mg
axapharm ag
B
FB
G
IP
CI
Sildenafil axapharm 50 mg
4 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 50 mg
axapharm ag
B
FB
G
IP
CI
Sildenafil axapharm 50 mg
12 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 50 mg
axapharm ag
B
FB
G
IP
CI
Sildenafil axapharm 100 mg
4 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 100 mg
axapharm ag
B
FB
G
IP
CI
Sildenafil axapharm 100 mg
12 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 100 mg
axapharm ag
B
FB
G
IP
CI
Sildenafil axapharm 100 mg
24 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 100 mg
axapharm ag
B
FB
G
IP
CI
A
Calmedoron
10 g
PR
PR
k.A.
Globules: 5 Active Agents
Weleda AG
D
FB
G
IP
18F-Fluorocholine ZRP
Durchstechflasche(n)
PR
PR
k.A.
Injektionslösung zur i.v. Applikation: Fluorocholinum(18-f) zum Zeitpunkt der Abfüllung 0.02-4 G/ml
Universitätsspital
Zürich
A
FB
G
IP
PP
Eylea
syringe(s)
913.48
1063.35
k.A.
Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl
Bayer (Schweiz) AG
B
FB
G
Tobramycin B. Braun 1
mg/ml
10 x 80 ml
PR
PR
k.A.
Infusion solution: Tobramycinum 1 mg/ml
B. Braun Medical AG
B
FB
G
Tobramycin B. Braun 3
mg/ml
10 x 80 ml
PR
PR
k.A.
Infusion solution: Tobramycinum 3 mg/ml
B. Braun Medical AG
B
FB
G
Tobramycin B. Braun 3
mg/ml
10 x 120 ml
PR
PR
k.A.
Infusion solution: Tobramycinum 3 mg/ml
B. Braun Medical AG
B
FB
G
IP
CI
Clopidogrel-Mepha Teva 75
28 Tablet(s)
PR
PR
k.A.
Mepha Pharma AG
B
FB
G
IP
CI
Clopidogrel-Mepha Teva 75
84 Tablet(s)
PR
PR
k.A.
Mepha Pharma AG
B
FB
G
IP
CI
Diclo-Acino 50
10 Capsule(s)
PR
PR
k.A.
rektale Kapseln: Diclofenacum Natricum 50 mg
Acino Pharma AG
B
FB
G
IP
CI
Diclo-Acino 100
5 Capsule(s)
PR
PR
k.A.
rektale Kapseln: Diclofenacum Natricum 100 mg
Acino Pharma AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
